Dr. Mark Wyatt
Mark is an investment Director on the Technology Team and has particular expertise in healthcare and clean technology sectors.
He re-joined Enterprise Ventures in 2010 following two years as Bioscience Ventures Manager at London-based Imperial Innovations where is was responsible for the formation of new, and management of existing, early- stage portfolio companies. His role at Imperial involved the analysis of new technology spin-out opportunities, predominantly in the life sciences area, and working with founding academics and incoming management teams to build valuable investment propositions.
Prior to joining Imperial, Mark had spent the previous five years with Enterprise Ventures’ Technology team based in the North West, and before that, six years at Merlin Biosciences, a venture capital and advisory company dedicated to the life sciences sector.